The Procter & Gamble Co:戦略・SWOT・企業財務分析

◆英語タイトル:The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8014905
◆発行会社(調査会社):MarketLine
◆発行日:2017年11月12日
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

The Procter & Gamble Co – Strategy, SWOT and Corporate Finance Report
Summary

The Procter & Gamble Co – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

The Procter & Gamble Company (P&G or ‘the company’) is one of the world’s largest consumer goods companies. The company’s product portfolio includes beauty, health, fabric, home, baby, feminine, family, and personal care products. P&G markets its products under various brands such as Head & Shoulders, Tide, Ariel, Olay, Pantene, Pampers, Gillette, Braun, Fusion, Bounty, Vicks and Oral-B. The company distributes its products through several mass merchandisers, grocery stores, membership club stores, baby stores, specialty beauty stores, high-frequency stores, e-commerce, pharmacies, drug stores and department stores. It has presence in Asia Pacific, Europe, the Middle East and Africa (EMEA), Latin and North America. P&G is headquartered in Cincinnati, Ohio.

Scope

- Detailed information on The Procter & Gamble Co required for business and competitor intelligence needs
- A study of the major internal and external factors affecting The Procter & Gamble Co in the form of a SWOT analysis
- An in-depth view of the business model of The Procter & Gamble Co including a breakdown and examination of key business segments
- Intelligence on The Procter & Gamble Co’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about The Procter & Gamble Co, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of The Procter & Gamble Co and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess The Procter & Gamble Co as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on The Procter & Gamble Co’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
The Procter & Gamble Co: Company Overview
The Procter & Gamble Co: Overview and Key Facts
The Procter & Gamble Co: Overview
The Procter & Gamble Co: Key Facts
The Procter & Gamble Co: Key Employees
The Procter & Gamble Co: Key Employee Biographies
The Procter & Gamble Co: Major Products and Services
The Procter & Gamble Co: Company History
The Procter & Gamble Co: Management Statement
The Procter & Gamble Co: Locations and Subsidiaries
The Procter & Gamble Co: Key Competitors
The Procter & Gamble Co: Company Analysis
The Procter & Gamble Co: Business Description
The Procter & Gamble Co: SWOT Analysis
The Procter & Gamble Co: SWOT Overview
The Procter & Gamble Co: Strengths
The Procter & Gamble Co: Weaknesses
The Procter & Gamble Co: Opportunities
The Procter & Gamble Co: Threats
The Procter & Gamble Co: Corporate Financial Deals Activity
The Procter & Gamble Co: Financial Deals Overview
The Procter & Gamble Co: Targets and Partners
The Procter & Gamble Co: Top Deals 2013 – 2017YTD*
The Procter & Gamble Co: Advisors
The Procter & Gamble Co: Top Legal Advisors
The Procter & Gamble Co: Top Financial Advisors
The Procter & Gamble Co: Capital Raising
The Procter & Gamble Co: Partnership
The Procter & Gamble Co: Divestments
The Procter & Gamble Co: Recent Developments
The Procter & Gamble Co: News and Events Summary
The Procter & Gamble Co: Business Expansion
The Procter & Gamble Co: Corporate Governance
The Procter & Gamble Co: Financial Performance
The Procter & Gamble Co: Red Flags/DistressSignals
The Procter & Gamble Co: Regulatory and Legal Events
The Procter & Gamble Co: Research & Development
The Procter & Gamble Co: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: The Procter & Gamble Co: Key Facts
Table 2: The Procter & Gamble Co: Key Employees
Table 3: The Procter & Gamble Co: Locations and Subsidiaries
Table 4: The Procter & Gamble Co: Key Competitors
Table 5: The Procter & Gamble Co: Deal Activity by Deal Type - Volume (TTM*)
Table 6: The Procter & Gamble Co: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: The Procter & Gamble Co: Targets and Partners
Table 8: The Procter & Gamble Co: Top Deals 2013 - 2017YTD*
Table 9: The Procter & Gamble Co: Legal Advisor Ranking by Value (US$m)
Table 10: The Procter & Gamble Co: Financial Advisor Ranking by Value (US$m)
Table 11: The Procter & Gamble Co: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 12: The Procter & Gamble Co: Capital Raising by Deal Type (2013 - YTD*2017)
Table 13: The Procter & Gamble Co: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 14: The Procter & Gamble Co: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 15: The Procter & Gamble Co: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 16: The Procter & Gamble Co: Divestments by Geography (2013 - YTD*2017)
Table 17: The Procter & Gamble Co: News and Events Summary
Table 18: The Procter & Gamble Co: Business Expansion
Table 19: The Procter & Gamble Co: Corporate Governance
Table 20: The Procter & Gamble Co: Financial Performance
Table 21: The Procter & Gamble Co: Red Flags/DistressSignals
Table 22: The Procter & Gamble Co: Regulatory and Legal Events
Table 23: The Procter & Gamble Co: Research & Development
Table 24: The Procter & Gamble Co: Strategy and Operations

★海外企業調査レポート[The Procter & Gamble Co:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medibank Private Limited (MPL):企業の財務・戦略的SWOT分析
    Medibank Private Limited (MPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Domtar Corp (UFS):企業の財務・戦略的SWOT分析
    Domtar Corp (UFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Vietnam Electricity:企業の戦略的SWOT分析
    Vietnam Electricity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Hainan Airlines Co Ltd:企業の戦略・SWOT・財務分析
    Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Veritas (India) Ltd:企業の戦略・SWOT・財務情報
    Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vifor Pharma AG-製薬・医療分野:企業M&A・提携分析
    Summary Vifor Pharma AG (Vifor Pharma), a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tr …
  • Telefonica, S.A.:戦略・SWOT・企業財務分析
    Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report Summary Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Deyaar Development:企業の戦略・SWOT・財務情報
    Deyaar Development - Strategy, SWOT and Corporate Finance Report Summary Deyaar Development - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Genfit SA (GNFT):医療機器:M&Aディール及び事業提携情報
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program …
  • Xintela AB (XINT):企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also p …
  • Fusion Telecommunications International, Inc.:企業のM&A・事業提携・投資動向
    Fusion Telecommunications International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fusion Telecommunications International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • Arete Industries Inc (ARET):企業の財務・戦略的SWOT分析
    Summary Arete Industries Inc (Arete Industries) is an oil and gas company that operates pipeline stations. The company operates a natural gas gathering system located in Campbell County, Wyoming. Arete Industries gas gathering systems comprise coated steel pipeline transporting coal bed methane. The …
  • Quantum Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Quantum Pharma Ltd (Quantum Pharma), a subsidiary Clinigen Group Plc, is a manufacturer and supplier of unlicensed medicines. The company develops, manufactures, and supplies niche pharmaceutical products. It offers dermatology products, branded generics and vitamins, borderline substances, …
  • TSO3 Inc (TOS)-医療機器分野:企業M&A・提携分析
    Summary TSO3 Inc (TSO3) is a medical device company that designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization pr …
  • KVK-Tech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary KVK-Tech Inc (KVK-Tech) is a developer and manufacturer of generic pharmaceuticals. The company's products include benzphetamine HCL, betaxolol, chlorphen-12, cyclobenzaprine HCL, diethylpropion HCL, hydroxyzine HCL, indomethacin extended release, phentermine hydrochloride USP, phendimetrazi …
  • Schott AG:企業の戦略的SWOT分析
    Schott AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Cerevance Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cerevance Inc (Cerevance) is a pharmaceutical company that strives to develop medicines for the treatment of neurological and psychiatric diseases. It is also developing preclinical and clinical programs for Parkinson's disease, L-Dopa induced dyskinesia, cognitive impairment, neuroinflammat …
  • Tokyo Electric Power Company Holdings Inc (9501):企業の財務・戦略的SWOT分析
    Tokyo Electric Power Company Holdings Inc (9501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Pharmaron Beijing Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmaron Beijing Co Ltd (Pharmaron) is a life science service company that provides drug research and development services in the areas of chemistry, biology, pharmacology, DMPK, toxicology, and chemical development. The company's service offerings include synthetic, medicinal and analytica …
  • Aitken Spence Hotel Holdings PLC:企業の戦略・SWOT・財務情報
    Aitken Spence Hotel Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Aitken Spence Hotel Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆